相关实验视频

Updated: May 6, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.0K

针对型肝炎病毒的强效二元烯亚NS5A抑制剂的计算设计

Wissal Liman1, Mehdi Oubahmane2, Nouhaila Ait Lahcen2

  • 1Bioinformatics Laboratory, College of Computing, University Mohammed VI Polytechnic, Ben Guerir, Morocco.

Scientific reports
|December 31, 2024
PubMed
概括

研究人员使用QSAR和分子建模设计了新的C型肝炎病毒 (HCV) NS5A抑制剂. 这些化合物显示出作为抗HCV有效治疗剂的潜力,解决了对新治疗策略的需求.

关键词:
接收人 接收人在HCV病毒感染的过程中,在MMGBSA中,我们可以看到MMGBSA.在NS5A中,它是NS5A.菲尼尔提亚醇是一种在QSAR中使用QSAR.

更多相关视频

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

1.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

371

相关概念视频

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97